Urethane (ethyl carbamate), 1, 2-benzanthracene, triethylene melamine (TEM), and P-propiolactone have been shown to be tumour-initators for the skin of the mouse. Two derivatives of urethane (ethyl N-phenylcarbamate and ethyl Nmethylcarbamate) showed similar activity, but the results required confirmation (Graffi et al., 1953; Salaman and Roe, 1953; Roe and Salaman, 1955) .
In the cases of urethane, and TEM, application to the skin in near-lethal doses without croton oil gave rise to no tumours (nor to any recognisable histological change in the skin); and it was concluded that these substances are non-carcinogenic for mouse skin. On the other hand both gave rise to tumours of mouse lung, and TEM has been shown to give rise to sarcomata when injected subcutaneously in the rat (Walpole et al., 1954) . 1,2-Benzanthracene is probably very weakly carcinogenic for mouse skin and other tissues (see Steiner and Falk, 1951 , for a review of the evidence); but in contrast to its weak carcinogenic action, its tumour-initiating action is strong. 3-Propiolactone, which had not been tested for carcinogenicity in mouse-skin at the time its tumour-initiating effect was described (Roe and Salaman, 1955) , has subsequently been found to be weakly carcinogenic for this tissue (Roe and Glendenning, 1956 ). It had previously been found to give rise to sarcomata following subcutaneous injection in the rat (Walpole et al., 1954) . As in the case of 1,2-benzanthracene, the tumour-initiating action of P-propiolactone in mouse skin is considerably stronger than its carcinogenic action.
It was suggested (Roe and Salaman, 1955) that there might be a relation between tumour-initiating activity for mouse skin and tumour-inducing activity for mouse lung.Ureth ane, TEM, and ethyl N-methylcarbamate possess both activities; 1,2-benzanthracene definitely possesses the first and possibly the second; many other substances were shewn to be without either action (including Myleran and colchicine). At the time this suggestion was made it was not known whether 3-propiolactone gave rise to tumours in mouse lung. More recently it has been found that intravenous injections of this substance (1 to 10 mg.) failed to increase the incidence of lung tumours in mice (Roe and Glendenning, 1956) . It seems therefore that there is no simple correlation between these two activities. There is at present no clear indication of the chemical basis of tumour-initiating action, and no evidence for a definite relation between tumourinitiation and any other biological activity, except perhaps carcinogenicity for other tissues or species (Roe and Salaman, 1955 ).
The present paper describes the results of tests of a further 20 substances for tumour-initiating action, and a third test of ethyl N-phenylcarbamate (phenylurethane) , which gave doubtful and negative results respectively on two previous occasions (Roe and Salaman, 1955, pp. 191 and 201) . Reasons for the choice of the 20 substances are briefly outlined below.
Selection of substances
A list of substances screened is given in Table I . It was found convenient to divide them into four classes: polycyclic hydrocarbons, aromatic nitrogen mustards, purine analogues, and miscellaneous substances. In the first class four substances were chosen for test, either because they were thought to be on the borderline between carcinogenicity and non-carcinogenicity, or because they were the parent substances of potent carcinogenic agents. As pointed out above the tumour-initiating action of 1,2-benzanthracene is'far stronger than its carcinogenic action, and it was thought possible that the same might be true for other polycyclic hydrocarbons.
Anthracene has been tested for carcinogenicity by many workers, but never with a positive result. Kennaway (1924a) , who pointed out that workmen handling purified anthracene do not suffer from skin lesions, failed to produce skin tumours in mice with this substance (see also Kennaway, 1924b; Kennaway and Hieger, 1930) . Barry et al. (1935) , and later Bachmann et al. (1937) (Demerec, 1949 , quoted by Auerbach, 1949 .
Deoxycholic acid.-Occasional epitheliomata have been seen in mice painted with deoxycholic acid repeatedly over long periods (Bachmann et al., 1937; Badger et al., 1940; Cook, Kennaway and Kennaway, 1940) , and subcutaneous injection into mice has given rise to sarcomata after a prolonged period (Badger et al., 1940) . Klein (1952) found that deoxycholic acid applied to the skin gave rise to no tumours either when used alone or in conjunction with croton oil. Deoxycholic acid has been found to be mutagenic for bacteria (Witkin, 1947; Jensen et al., 1951) , and for Drosophila by Demerec (1948) , but not by Jensen et al., (1951) .
Phenanthrene has been tested for carcinogenicity both on mouse-skin (Kennaway 1924a (Kennaway , 1924c Kennaway and Hieger, 1930) and also by subcutaneous injection into mice (Steiner, 1955) to the backs of mice for a year; the yield of tumours was not significantly higher than in croton oil controls. Demerec (1948) found phenanthrene to be nonmutagenic for Drosophila.
Pyrene.-Occasional papillomata have been seen on mouse skin following repeated applications of pyrene by Barry et al. (1935) , but not by Badger et al. (1940) . Graffi et al. (1953) tested pyrene in the same way as phenanthrene (see previous paragraph); the result was again negative. Demerec (1948) found it to be non-mutagenic for Drosophila.
The second class consisted of three aromatic nitrogen mustards. The first of these. N,N-di-(2-chloroethyl)-p-aminophenylbutyric acid (CB1348), was synthesized by Everett, Roberts, and Ross (1953) . It was found to have a more powerful tumour-inhibitory effect on the Walker rat carcinoma 256 than several hundred other biological alkylating agents, including a series of closely related mustards. (Ross et al., 1952) . Galton et al. (1955) Fahmy and Fahmy (1952) to be mutagenic for Drosophila, and by Gopal-Ayengar (1952) to produce chromosome abnormalities.
The other two substances of this class are the two isomers p-di-(2-chloroethyl)-amino-L-, and D-phenylalanine. The synthesis of these substances was described by Bergel and Stock (1954) . The same authors (1953) reported a remarkable difference in the tumour-inhibitory effects of the two isomers on the Walker rat carcinoma 256, the L-form showing strong inhibition of growth and the D-form only slight activity. Bergel et al., (1954) state that their colleagues, Dr. Elson and Professor Koller, have found similar differences in the effects of the two isomers on the blood picture of the normal rat, and in the production of chromosome abnormalities.
The isomers have not been tested separately for carcinogenicity, but in an experiment (Haddow: personal communication) in which the racemic mixture was injected subcutaneously in arachis oil weekly for 12 weeks into 10 female rats, a sarcoma arose at the injection site in one rat 18 months after the final injection. Two out of 20 mice, similarly treated, developed sarcomata at the injection site. For the reason stated in the case of CB1348 this result is also indecisive. Fahmy and Fahmy (1953; and personal communication) found that both the D-and L-forms were mutagenic.
The third class consisted of four purine analogues. Three of them have been shown to have tumour-inhibitory or antileukaemic effects: 2,6-diaminopurine (2,6-DAP) by Burchenal et al. (1949) and Skipper et al. (1950) ; 6-mercaptopurine (6-MIP) by Clarke et al. (1953), and Burchenal et al. (1953) ; and 8-azaguanine (8-AG) by Kidder and Dewey (1949 ), Gellhorn et al. (1950 ), and Law (1950 . It will be recalled that two known tumour-initiators, urethane and TEM (Roe and Salaman, 1955) , also possess these properties. 2,6-DAP and 6-MP have both beenii shown to induce chromosome abnormalities, the former in mice by Dustin (1950) , and the latter in Allium and Pisum by Kihlman (1952) . 8-AG was found by Novick and Szilard (1951) to be mutagenic for E. coli.
2,6-Diamino-8-phenylpurine, a purine analogue recently synthesized by Mr.
G. M. Timmis of the Chester Beatty Research Institute, was also tested. Little is known of its biological activity at present.
The fourth class consisted of 10 miscellaneous substances, which were chosen for test for a variety of reasons.
Phenylurethane, chemically and pharmacologically related to urethane, had been tested twice before, with a doubtful and a negative result respectively (Roe and Salaman, 1955) . The properties of this substance were discussed in that paper. In those tests 0-5 g. and 1.32 g., respectively, were applied. In the test described below a total of 1.8 g. was applied.
Potassium arsenite, the active constituent of Fowler's solution, was selected because of its antileukaemic action. It was first used in the treatment of leukaemia by Valentiner (1865), and Lissauer (1865), but went out of fashion with the introduction of radiotherapy. Forkner (1938) reintroduced it, and Flory et al. (1943) found it efficacious in several strains of mouse leukaemia. Skipper et al. (1951) found that potassium arsenite, like urethane, nitrogen mustard, folic acid antagonists, and certain purine analogues (including 2,6-DAP and 8-AG), inhibited the incorporation of labelled formate in the synthesis of nucleic acid purines. Warren (1943) found that arsenite depressed respiration and, probably as a secondary effect, accelerated aerobic glycolysis (urethane also inhibits aerobic glycolysis: Quastel and Wheatley, 1933, 1934) . Piton (1929) found that potassium arsenite stimulated mitosis in the intestinal epithelium of the mouse, but that this was followed by death of the mitotic cells. Leitch and Kennaway (1922) painted mice thrice-weekly with a 0.12 per cent solution of potassium arsenite in ethanol, and observed an epithelioma and a benign wart in 1 out of the 30 mice which survived for 3 months or more. The epithelioma had metastasised to the lung. Askanazy (1926) records the development of stomach neoplasms in 4 rats after prolonged administration of potassium arsenite in the drinking water. Cholewa (1935) observed lung tumours in mice given potassium arsenite by mouth, and a sarcoma of the ear in one of two rabbits injected subcutaneously with the substance. Evidence for the carcinogenicity of potassium arsenite, and other arsenical compounds, for both man and experimental animals, is reviewed and discussed by Neubauer (1947) .
Three substances, aspirin, saccharin, and vanillin, were chosen for no other reason than that they are commonly ingested. Hartwell (1951) lists four experiments in which aspirin was tested for carcinogenicity in rats; in three the substance was given by mouth, and in one subcutaneously in lard. No tumours were seen in any of these experiments. Fitzhugh, Nelson, and Frawley (1951) reported an increased incidence of abdominal lymphosarcomata in rats fed for 102 weeks or more on a diet contain 5 per cent saccharin, but the number of animals involved was small (4 with abdominal lymphosarcomata among 18 rats which survived for 1 year or more). Vanillin has apparently not been tested for carcinogenicity.
Acrolein, an unsaturated aldehyde (CH2 CH.CHO), was chosen mainly because it is actively mutagenic for Drosophila (Rapoport, 1948 (Salaman and Roe, 1953; Roe and Salaman, 1955) .
Monosodium maleic hydrazide was found to exert a growth-inhibitory effect on certain plants by Schoene and Hoffmann (1949) , Wittwer and Sharma (1950) found that the simultaneous administration of oxalacetic acid with urethane to mice considerably increased the incidence of lung tumours due to the latter. In view of the possible relation between initiating action for mouse skin and lung tumour induction (Roe and Salaman, 1955) it was thought advisable to test oxalacetic acid for initiating action.
MATERIALS AND METHODS

Mice
These were of the " S " strain as used in previous screening experiments. (Salaman and Roe, 1953; Roe and Salaman, 1955 Croton oil.-Two batches (Batches I and II) of oil were used. Both were supplied by Messrs. Stafford Allen. They had been prepared by simple expression of the seeds of Croton tiglium, at different dates. Batch II was more irritant than Batch I, and was used at a lower concentration. In other respects the two batches of oil appeared similar (Roe, 1956b) .
Solvents.-Either acetone (AR grade, British Drug Houses Ltd.) or methanol (James Burrough, Ltd.) was used for all substances, except those of Class III and monosodium maleic hydrazide; for the latter four substances 50 per cent aqueous carbowax 300 (polyethylene glycol of average molecular weight 300, obtained from General Metallurgical and Chemical Co., Ltd.) was used.
Methods
The techniques of application of solutions, recording of tumours, examination of mice for lung adenomas at post-mortem, and histological examination, have been fully described (Roe and Salaman, 1955) . The choice of dose and of dose-schedule for individual test substances was governed by two factors: solubility in a suitable solvent, and toxicity. Nontoxic substances were applied at the highest concentration obtainable in a suitable solvent, thrice weekly until 10 applications had been given. Toxic substances were applied 10 times at weekly intervals, at the highest tolerated concentration.
In all cases (except that of pheny]urethane) croton oil treatment was begun between 22 and 30 days after the first application of the test substance.
Further details of the dose-schedules for individual substances are given below and in Table I .
EXPERIMENTAL
Three lots of mice, obtained at different times from the same animal-breeder, were used. From each lot 20 control mice were selected at random to be treated with croton oil only: these will be referred to as control groups A, B, and C, respectively. The remaining mice of each lot were divided into groups of 14 to 25 mice, for treatment with the test substances followed by croton oi].
Treatment with croton oil differed slightly for the three lots of mice. Table I . Those tests in which treatment with croton oil overlapped that with the test substance are marked with an asterisk. Because of the low solubility of anthracene (Group 1) at each of the 10 treatments (thrice weekly) two applications of 0 3 ml. 0 5 per cent were given, separated by an interval of 30 minutes.
The toxicity of the three aromatic nitrogen mustards (Groups 5 and 7) necessitated a close watch on the condition of the mice during treatment. A fall in average body weight was taken as an indication to reduce the dose. Details of dosage' are given in Table I. 8-Hydroxyquinoline (Group 15) proved too toxic at the concentration tested (0-5 per cent) for more than 6 weekly applications to be given.
In the case of phenylurethane (Group 18) Table I shows the numbers of survivors, of tumour-bearing mice, and of tumours, one week after the end of croton oil treatment.
A few papillomata were seen in two out of three of the control groups treated with croton oil only. In several of the test groups the incidence of these tumours exceeded that in the corresponding control group. In some cases the difference was marked, namely, deoxycholic acid (Group 2), phenanthrene (Group 3), pyrene (Group 4), CB1348 (Group 5), the isomeric phenylalanine mustards (Groups 6 and 7), phenylurethane (Group 18), and saccharin (Group 20) . Statistical analysis of the results by the t-test, however, showed that only in the cases of CB1348 (Group 5) and phenylurethane (Group 18) are the differences significant: the test for the difference between the mean numbers of tumours per mouse in Groups 5 and C gives t -3.07 on 34 degrees of freedom (d.f.), P < 0-01; that between Groups 18 and A gives t = 2.33 on 32 d.f., 0-05 > P > 0-01.
Malignant tumours.-Shortly after the end of croton oil treatment all mice, except those of Groups B and C and a few papilloma-bearing mice of Groups 5 (6 mice), 6 (3 mice), and 7 (5 mice), were killed and examined post mortem for lung adenomata (see below). Mice of Group C continued to receive weekly applications of 0.17 per cent Batch II croton oil; the subsequent development of further tumours in this Group has been reported elsewhere (Roe, 1956b; Group 5) . Mice of Group B, and those of Group 5, 6, and 7 which were not killed at the end of croton oil treatment, were kept without further treatment and examined weekly for the development of malignant tumours of the skin.
So far no definitely malignant tumour has been seen in Group B. However there has been one tumour which arose as a subcutaneous nodule and later (8 months after the end of croton oil treatment) became ulcerated. A biopsy was taken from this tumour 10 days after ulceration was first observed.
Microscopically it appeared to be an epithelioma of low-grade malignancy; it had infiltrated the dermis and extended down to the panniculus carnosus, but at no place was infiltration of this muscle layer seen. The mouse died two weeks after biopsy, further sections of the tumour still showed no infiltration of the muscle layer. This tumour is regarded as "probably malignant" (Roe, 1956a) . One of the 5 mice retained from Group 7 (L-phenylalanine nitrogen mustard and croton oil) which was kept under observation developed an undifferentiated carcinoma. This tumour first appeared malignant 3 weeks after the end of croton oil treatment. Histologically it showed penetration of the panniculus carnosus ( Fig. 1 and 2 ) and there was a metastasis in the regional lymph node.
One of the 3 mice retained from Group 6 (D-phenylalanine nitrogen mustard and croton oil) developed a squamous carcinoma 15 weeks after the end of croton oil treatment. Histologically this tumour also showed penetration of the panniculus carnosus.
No malignant tumours have so far arisen in mice treated with CB1348 and croton oil (Group 5).
Observation of the survivors of these groups is being continued. It is concluded that both CB1348 and phenylurethane are effective initiators of skin tumour formation in the mouse. The fact that other substances (deoxycholic acid, phenanthrene, pyrene, saccharin, and the two isomeric phenylalanine mustards) in conjunction with croton oil gave rise to more papillomata than croton oil only, is of doubtful significance. On the other hand, the fact that a malignant tumour arose in Group 6 and in Group 7 among the very few mice kept for observation, suggests that the two isomeric phenylalanine mustards, if given in higher dosage, might shew a significant tumour-initiating effect. Anthracene, 4 purine analogues, and 8 miscellaneous substances, all gave negative results.
(B) Histological findings in the skin
Previously it has been shown that among a wide variety of substances tested there is no correlation between the initiation of skin tumour formation and the production of hyperplasia of the epidermis (Salaman and Roe, 1953; Roe and Salaman, 1955) . No correlation is found even within a group of substances related to each other chemically and pharmacologically. For instance, among a limited number of alkylating agents, nitrogen mustard (HN2) and R48 (N,N-di-(2-chloroethyl)-3-naphthylamine) produced a characteristic type of epidermal hyperplasia, but did not initiate tumour formation, TEM (triethylene melamine) produced no recognisable change in the skin, but was an effective initiator, while Myleran (1, 4-dimethane-sulphonoxybutane) was inactive in both respects.
The three aromatic mustards included in the present series were tested for action on the skin. They were applied twice, with one week's interval, at a concentration of 0-33 per cent (i.e. 3 times the highest concentration used in the main experiment), and biopsy specimens of the treated skin were removed three days after the 1st and 2nd applications. CB1348 (0.33 per cent) caused a slight patchy epidermal hyperplasia, with some cellular enlargement, and reduction in numbers of sebaceous glands. This effect was similar in character to that due to HN2 (0.2 per cent, Salaman and Roe, 1953) , but less in degree. Neither of the two phenylalanine mustards (0.33 per cent) produced any recognisable changes in the skin.
(C) Incidence of pulmonary adenomata All mice except those of Groups B and C, and a few papilloma-bearing mice in Groups 5, 6, and 7, were killed shortly after the end of croton oil treatment and examined post mortem for lung adenomata.
Mice of Groups 6 and 7, treated with the dextro-and laevo-phenylalanine mustards respectively, and croton oil, had a high incidence of lung tumours (47 in 13 out of 18 mice examined, and 55 in 11 out of 13 mice examined, respectively). The highest incidence observed among the other test groups was in Group 5, treated with CB1348 and croton oil (13 in 7 out of 12 examined), and in this case the incidence is only slightly above that seen in untreated mice of the same strain (unpublished data).
Applications of croton oil to the skin are not now believed to increase the incidence of pulmonary tumours in mice (Roe, 1956b) , though at one time (Roe and Salaman, 1955) it was thought that they might do so. In the present experiment the incidence of lung tumours in mice of Group A, treated with croton oil only, was 17 in 10 out of 17 mice examined.
It is concluded that the high incidence of lung tumours in mice of Groups 6 and 7 resulted from treatment with the phenylalanine nitrogen mustards.
DISCUSSION
The present series of tests for initiating action extends previously reported series (Salaman and Roe, 1953; Roe and Salaman, 1955) , using similar methods.
The substances chosen for test fall into 4 classes: polycyclic hydrocarbons, aromatic nitrogen mustards, purine analogues, and miscellaneous. The last class contains some commonly used drugs and food additives, and some substances chosen either because of reported doubtful carcinogenicity, or because of their chemical relation to other initiators.
Only two substances, phenylbutyric acid nitrogen mustard (CB1348) and phenylurethane, initiated the development of tumours in significantly higher numbers than in corresponding control groups. In six other cases (deoxycholic acid, phenanthrene, pyrene, the dextro-and laevo-phenylalanine nitrogen mustards, and saccharin) tumour incidence was higher than in controls, but the differences, though suggestive, are not significant by accepted standards.
There is no reason to abandon the view previously expressed (Roe and Salaman, 1955) , that substances which initiate tumour development in the skin are either carcinogenic for both the skin and other tissues (e.g. 3, 4-benzpyrene and the other EXPLANATION OF PLATES FIG. 1.-Carcinoma arising from the dorsal skin of a mouse treated with L-phenylalanine nitrogen mustard and croton oil (Group 7). The tumour, which first appeared to be malignant 3 weeks after the end of croton oil treatment, has penetrated the panniculus carnosus.
[Stain: Haematoxylin and eosin-Biebrich scarlet On the other hand, the suggestion that there is a correlation between initiating action in skin and adenoma production in lung (Roe and Salaman, 1955) has not been supported by the results now recorded. For instance, among the three aromatic nitrogen mustards tested, CB1348 acted as an initiator for the skin but did not significantly increase the incidence of lung adenomas, while both the isomeric phenylalanine mustards markedly increased the incidence of lung adenomas but were ineffective as initiators for the skin. Further, as has been mentioned above, ,-propiolactone is an active initiator in skin but does not increase the incidence of lung adenomas.
One of the most interesting findings in previous experiments was that a substance can be a powerful initiator of tumour development in the skin without producing epidermal hyperplasia or any other recognised histological change (e.g. urethane: Salaman and Roe, 1953 ; TEM: Roe and Salaman, 1955) . Among the substances included in the present series, of the two which showed definite initiating activity CB1348 caused very slight histological changes [similar in nature to, but very much less marked than, those caused by HN2 or R48, neither of which are initiators (Salaman and Roe, 1953) ] and phenylurethane (like the more powerful initiator, urethane) caused no detectable change whatever (Roe and Salaman, 1955) .
Phenylurethane produced no tumours when applied alone repeatedly to skin (see p. 372). A corresponding test of CB1348 is not complete. All substances or procedures at present known which "promote " tumour-development [e.g. croton oil, iodoacetic acid, chloracetophenone , mechanical trauma (PulLinger, 1945) ] produce epidermal hyperplasia, and it therefore seems probable that a complete carcinogen, in contradistinction to an initiator, must have this property. SUMMARY 1. A further 20 substances have been tested for tumour-initiating action on mouse-skin.
2. Among 3 aromatic nitrogen mustards tested, one, NN-di-(2-chloroethyl)-p-aminophenylbutyric acid (CB1348), was found to be an initiator of tumour formation. The two others, p-di-(2-chloroethyl)-L-and -D-phenylalanriine, each gave rise to an incidence of papillomata which was not significantly higher than the control level.
3. Four of the other substances tested, deoxycholic acid, phenanthrene, pyrene, and saccharin, also gave borderline results. 4. Phenylurethane which gave borderline and negative results, respectively, in two previous tests, gave a significantly positive result in a third test.
5. Anthracene, aspirin, vanillin, monosodium maleic hydrazide, and 4 purine analogues, were among the substances which gave negative results.
6. A few papilloma-bearing mice from the groups treated with the 3 aromatic nitrogen mustards, and the whole of a croton oil control group, were kept under observation for 8 months after the end of treatment. A malignant epithelioma appeared in both the L-and D-phenylalanine nitrogen mustard groups 3 and 15 weeks, respectively, after the end of treatment. No malignant tumours were seen in any other group.
7. The majority of mice were killed and examined for lung adenomata shortly after the end of treatment. Among all the substances tested, only the dextroand laevo-phenylalanine mustards increased the incidence of these tumours.
8. The results are discussed.
We are grateful to Professor Bergel for suggesting the use of diethyl carbonate, and the 3 aromatic nitrogen mustards, and to Professor Boyland for suggesting the use of maleic hydrazide and saccharin.
